<div id="readability-page-1">11:15 AM EST, 12/29/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking lower late Monday morning, declining 0.44% to 1,684.72 on the S&amp;P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and accommodations booking company trivago (TRVG), which rose 4% and 1%, respectively. They were followed by internet browser company Opera (OPRA) and internet advertising firm Criteo ( CRTO ) , which were up 0.5% and 0.2% respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and telecommunications operator Nokia (NOK), which fell 1.4% and 1% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and lender ING (ING), which were off 2.1% and 1%, respectively.From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company NuCana ( NCNA ) , which advanced 7.5% and 1%, respectively. They were followed by biopharmaceutical company Amarin ( AMRN ) , which increased 0.3%.The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO), which plummeted 90%, followed by biotech company Trinity Biotech (TRIB), which dropped 13%. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and mining company BHP Group ( BHP ) , which lost 7.4% and 2.2%, respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

MREO

NCNA

AUTL

European equities traded in the US as American depositary receipts fell 0.44% to 1,684.72 on the S&P Europe Select ADR Index. Notable gainers included Cellectis (CLLS) and trivago (TRVG), rising 4% and 1%, respectively. Decliners included Novo Nordisk (NVO) and Nokia (NOK), down 1.4% and 1%. From the UK, Autolus Therapeutics (AUTL) and NuCana (NCNA) gained 7.5% and 1%, while Mereo BioPharma Group (MREO) plummeted 90%.

fidelity

Novo Nordisk AS

Nokia

Mereo Biopharma

Nucana

Autolus Therapeutics

European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading